Burning Rock Biotech Ltd (BNR)

Burning Rock Biotech Ltd (BNR) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $158M; returns 1 day -10.8%, 1 week -8.4%, 1 year +12.6%.

Burning Rock Biotech Ltd. (BNR) is a Chinese company focused on precision oncology, applying next-generation sequencing (NGS) technology. It operates in two segments: NGS-based therapy selection testing for late-stage cancer patients and cancer early detection, which is in the clinical validation stage.

Groups BNR belongs to

• China Companies
• China Healthcare
• Oncology
• Biotechnology
• Precision Medicine
• Early Cancer Detection
• Health Diagnostics and Imaging
• Life Sciences Tools & Services
• Healthcare Technology
• R&D
• China Market

BNR financial model: income statement, cash flow and balance sheet